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ABSTRACT
OBJECTIVE: The objective of this selective EBM review is to determine whether or not
instrument assisted soft tissue manipulation (IASTM) is an effective therapy in
decreasing patient reported pain originating from musculoskeletal sources.
STUDY DESIGN: Systematic review of three randomized controlled trials published
between 2007-2016, all in English language.
DATA SOURCES: Three randomized controlled studies, which studied the effects of
IASTM on various musculoskeletal regions of patient reported pain compared to patients
who received other forms of treatment, were obtained using PubMed.
OUTCOMES MEASURED: The outcome of each study was a patient reported decrease
in pain using a visual analog scale (VAS) after IASTM intervention and an increase in
functional ability using an Oswestry Disability Index (ODI). These results were
compared to the patient’s responses on the VAS and ODI at baseline prior to beginning
the study.
RESULTS: All three RCTs determined that pain decreased over time after any form of
intervention, regardless of if it was IASTM or each individual control group.
CONCLUSIONS: Based on the results of these three RCTs, it appears there is a decrease
in MSK for patients who underwent a trial of IASTM therapy. This seemed to last over a
significant amount of time after the intervention was applied. Further investigation is
warranted to determine if IASTM is more beneficial when applied to chronic versus acute
injuries.
KEY WORDS: instrument assisted soft tissue manipulation, pain, musculoskeletal
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INTRODUCTION:
Patient complaints of musculoskeletal (MSK) pain is one of the most common,
and one of the most frustrating maladies health care providers are confronted with on a
daily basis. According to the American Academy of Orthopaedic Surgeons, over a
quarter of all Americans currently are suffering from a musculoskeletal condition1.
Musculoskeletal conditions are the second leading cause of primary care visits in the
country, and cost the United States over 850 billion dollars a year in health care
spending1. This paper strives to evaluate the efficacy of instrument assisted soft tissue
manipulation (IASTM) as a therapeutic approach for the treatment of musculoskeletal
pain conditions.
The American population is advancing in both age and weight, which directly
results in escalating MSK problems, making it imperative for health care providers to
understand MSK pain and complaints as well as how to effectively treat them1. Of the
1.25 billion ambulatory visits to physician’s offices in both outpatient and emergency
room settings in the United States in 2009-2010, over 105 million of these reported visits
were for MSK disorders2. Furthermore, the rising cost of healthcare in the United States
begs for alternative, cost effective solutions to current expensive treatments. The use and
subsequent misuse or overuse of opioids for chronic pain is quickly becoming a public
health concern3.

In a survey conducted by interviewing primary care health care

providers within the Veteran’s Administration Hospital system, it was found that provider
perceptions of barriers to reducing opioid prescription and increasing the use of nonpharmacologic treatments for pain were centered on availability and access to these forms
of treatment3. Some of the major barriers these providers listed were simply lack of
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education about alternative treatment options, belief that these options would increase
provider workload, and belief that patients would be resistant to alternative forms of
care3. These perceptions, on top of the rising cost of healthcare as well as the opioid
addiction crisis, prove just how important it is to find safer alternatives to MSK pain
complaints that are not only cost effective, but also therapeutically effective.
Almost everyone has been affected by MSK pain at least once in his or her
lifetime. As such, it is commonly known how debilitating these conditions can be.
MSK pain affects the muscles, bones, ligaments, joints, tendons, and nerves of the body.
MSK disorders encompass rheumatologic conditions such as rheumatoid arthritis,
degenerative conditions such as osteoarthritis, acute sports injuries and other orthopaedic
complaints2. MSK pain can be acute or chronic, and is typically caused by either injury
to a specific region, or repetitive use or overuse of a particular joint. Aside from pain,
other symptoms of MSK disorders include limited range of motion, edema, erythema,
aching, stiffness, inability or difficulty performing activities of daily living (ADLs),
fatigue, stress, increased sensitivity, and even depression4. Chronic widespread pain
conditions, such as fibromyalgia, are poorly understood as far as to how or why they
develop, but these conditions still contribute to the rising healthcare costs in the United
States4. Chronic pain conditions account for up to 15% of the general population and are
becoming more prevalent in primary care office visits throughout the country and
therefore must be managed accordingly4.
Currently, there are several acceptable paths when managing MSK pain.

A

plethora of treatment options exist, most of which are delivered in the primary care
setting by first contact clinicians such as general practitioners, physical therapists,
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chiropractors, and osteopaths5. Treatment options include, but are not limited to, nonpharmacological treatments such as self-management with ice, heat, and rest; exercise or
manual therapy; bracing or splinting; and pharmacologic interventions such as analgesics,
non-steroidal anti-inflammatory drugs (NSAID), opioids, and corticosteroid injections5.
Refractory symptoms of pain may even be managed with surgical intervention5.
The aforementioned treatment options all play effective roles in managing MSK
pain complaints. However, all patients should be viewed as individual entities, and as
such it should be understood that each patient might respond to each particular treatment
option much differently. Therefore, the more therapeutically and cost effective treatment
approaches that are accepted and available to patients, the better managed MSK pain can
be. It is proposed that IASTM be considered as an additional, therapeutically effective
way to manage multiple forms of MSK pain complaints. Hypothetically, IASTM should
be considered as an effective therapy for these conditions. This systematic review will
utilize three randomized controlled trials evaluating the efficacy of IASTM in managing
patients suffering from MSK pain as opposed to other forms of treatment.
OBJECTIVE
The objective of this selective EBM review is to determine whether or not
instrument assisted soft tissue manipulation (IASTM) is an effective therapy in
decreasing patient reported pain originating from musculoskeletal sources.
METHODS
This systematic review will study a population of both male and female patients
above the age of 18, with nonspecific musculoskeletal pain. The pain complaint could
originate from either the axial skeleton, such as the thoracic or lumbar region, or an
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extremity, such as the wrist or ankle. Any article selected must be published on or after
2007.

Any article selected must be a randomized controlled trial (RCT).

The

intervention being reviewed was IASTM. In Burke et al. IASTM was compared to
manual soft tissue manipulation, while in Lee et al. IASTM was compared to general
exercise techniques such as stretching and stationary bike work. Crothers et al. compared
IASTM to spinal manipulative therapy as well as a sham therapy of non-functional
ultrasound.
The key words utilized in searching for sources included “pain,” “instrument
assisted therapy,” “manual therapy,” “soft tissue,” and “musculoskeletal.” All articles
selected were published in peer-reviewed journals in the English language. The author
used PubMed to conduct this research. Articles were selected based on relevance to the
clinical question and that the outcomes of the studies mattered to patients (POEMs).
Inclusion criteria consisted of any study published on or after 2007. Exclusion critera
consisted of any form of pain that was not of MSK origin and patients under the age of
18. The statistics of this study were analyzed using mean change from baseline via
standard deviation, 95% confidence interval, as well as p-values as all RCTs utilized nondichotomous data.
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Table 1: Demographics and Characteristics of Included Studies
Study

Type

#
Patien
ts

Age
(Years)

Inclusion
Criteria

Exclusion Criteria

Withdrawn
from Trial
(W/D)

Interventions

Burke,
20071

RCT

26

30-40

1. ECG
confirmed CTS;
2.
Pain/paresthesia
in median nerve
distribution; 3.
self reported
pain of 33mm or
>on VAS; 4. at
least 2 of 8
other clinical
findings

1. >50 years old; 2.
Previous Tx
interventions with
surgery and/or
steroid injections;
3. Hx of wrist
trauma; 4. Hx of
other MSK
conditions; 5. Hx
of underlying
causes of CTS; 6.
No pending
lawsuits/insurance
claims

4

Instrument
Assisted Soft tissue
manipulation/Grast
on technique vs.
manual soft tissue
manipulation

Crothe
rs,
20166

RCT

143

30-60

1. 18 or older w/
nonspecific tspine pain of
any duration; 2.
Pain in T1-T12;
3.VAS score of
at least 2 out of
10; 4. Oswestry
Disability Index
score of >15%
at baseline

1. CI to manual or
Graston therapy; 2.
Referred pain to tspine; 3. Substance
abuse; 4. NonEnglish speaking;
5. Currently
receiving care for
t-spine pain from
other providers; 6.
Couldn’t commit
to study; 7.
compensation or
commenced
litigation

27

Instrument
Assisted Soft tissue
manipulation/Grast
on technique vs
spinal manipulative
therapy and a
sham, nonfunctional
ultrasound
treatment

Lee,
20165

RCT

30

25-55

1. Onset of low
back pain <12
weeks; 2.
Chronic low
back pain >than
90 days at time
of enrollment in
study

1. Hx of back
surgery; 2. spinal
fracture w/in 6
months; 3. spinal
tumor/malignancy;
4. meds for
psychiatric
disorder; 5.
exaggerated
complaints d/t car
or accident claim

0

Instrument
Assisted Soft tissue
manipulation/Grast
on technique vs.
general exercises
including
stretching and
stationary bike
work
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OUTCOMES MEASURES
Three RCTs were utilized in this review and the outcome that was measured was
patient oriented (POEMs). The outcome measured for this review was patient reported
decrease in pain from baseline. This was determined utilizing a Visual Analog Scale
(VAS). Crothers et al. also utilized an Oswestry Disability Index (ODI) in making these
determinations. Statistically, the outcome was measured using the decrease in selfreported pain using the VAS with a standard deviation presented as (+/-) as compared to
baseline at the beginning of the study. The change in mean, or average, of all of these
scores combined was then used to compare the comparison groups to the IASTM group.
RESULTS
Three RCTs were utilized to determine if IASTM was an effective treatment for
MSK pain. In each study utilized, all data collected and analyzed was continuous, thus
change in mean from baseline as well as confidence intervals were utilized for statistical
analysis. Crothers et al. used a three-treatment arm study to analyze the efficacy of
IASTM compared to both spinal manipulation therapy (SMT) as well as a placebo, which
was a non-functional ultrasound unit when treating patients with nonspecific thoracic
spine pain. Confidence Intervals (CI) was calculated at 95% across all three-treatment
arms as well as across different time points observed within the study. Time intervals
were at 1 week, 1 month, 3 months, 6 months, and 12 months. While p <0.01 across all
treatment arms with respect to time for both the VAS and ODI, there was not a
statistically significant difference between the type of therapy applied to the patient6.
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Table 2: Baseline Data for Entire Sample and Three Treatment Groups
Variable

All (N=143)

SMT (N=36)

IASTM (N=63)

Pain (0-10 VAS)

5.6 (2.0)

5.5 (2.0)

5.7 (2.1)

Sham US
(N=44)
5.5 (2.0)

Disability (0-100
ODI)

28.5 (10.4)

27.2 (10.2)

29.6 (11.1)

28.1 (9.9)

Table 3: Change in mean from baseline to end of study for pain severity and
disability with IASTM
Variable
Baseline
1 week into study
6 months post
study
Change in mean
5.7 (2.1)
4.7 (1.9)
3.5 (2.5
(VAS)
Disability (ODI)
29.6 (11.1)
22.6 (11.8)
16.2 (13.1)
Table 4: Confidence Intervals (95%) comparing IASTM to other modalities
Time
IASTM vs SMT
IASTM vs Sham US
1 week
-0.3 (-1.2, 0.5)
0.1 (-0.7, 0.8)
6 months
-0.4 (-1.4, 0.7)
-0.2 (-1.2, 0.8)
Burke et al. compared IASTM to manual soft tissue manipulation on patients
complaining of carpal tunnel syndrome (CTS).

Immediately after both treatment

interventions decreases were noted in pain ratings for the CTS wrist and no change was
noted in the control wrist. At three months post treatments, there was a slight increase in
pain ratings reported by the manual soft tissue group, whereas those patients that were
treated with IASTM maintained improved pain ratings7.

A p-value of < 0.05 was

considered statistically significant. The data in Table 5 was taken from Burke et al.
Table 5: Ratings of perceived pain as change in mean standard deviation (95% CI)
VAS (mm)
IASTM-CTS
IASTMManual-CTS
ManualControl
Control
Baseline
61.5 +/- 26.56
32.1 +/- 24.09
60.5 +/- 17.90
13.20+/-13.50
(46.5-76.5)
(18.5-45.7)
(49.4-71.6)
(4.8-21.6)
Immediate
9.8+/-12.54
5.6 +/- 8.93
15.4 +/- 19.62
5.4 +/-7.89
Post
(2.7-16.9)
(0.5-10.7)
(3.2-27.6)
(0.5-10.3)
3 Months Post 9.2 +/- 11.04
11.7 +/- 22.15
33.7 +/- 28.84
14.4 +/- 26.88
(3.0-15.4)
(0-24.2)
(15.8-51.6)
(0-31.1)
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Lee et al. compared the effects of IASTM to a general exercise program for
patients suffering from low back pain. Statistically significant effects of time were
observed in pain. VAS significantly improved in the IASTM group from pre intervention
to post intervention (IASTM 25.5 +/- 7.3mm vs 50.6 +/- 12.8mm, p<0.001; Exercise
Program 44.6 +/- 12.9 vs 48.9 +/- 14.6, p=0.334). 8 The data for the table below was
taken from Lee et al.
Table 6: Comparing VAS scores between IASTM and Exercise groups pre and post
treatment
Group
Pre-Intervention
Post-Intervention
IASTM
50.6 +/- 12.7
25.5 +/- 7.3
Exercise Program
48.9 +/- 14.6
44.6 +/- 12.9
DISCUSSION
All three studies demonstrated the efficacy of IASTM in relieving MSK pain. In
the Crothers study, it was found that no matter what the intervention was, all three groups
found a significant improvement in their pain over time, including from the sham, nonworking ultrasound unit.6 This particular study focused on the thoracic spine region of
the body as the primary pain source. A strength of this study was that the pain could be
for any length of time, both chronic or acute; however this could also be seen as a
weakness in that it was unspecified how long each participant suffered from their current
pain complaint as well as if this effected how responsive they were to each respective
intervention. Another limitation to this study was that disproportionate numbers of
patients were randomly allocated to the three groups. There were 36 patients in the SMT
group, 63 in the IASTM group, and 44 in the sham group6. This result may have had an
adverse effect on the statistical power and analyses of each treatment arm. Another
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strength to this study was that follow up ranged from one week to one year after each
intervention. It is promising that even one year after the intervention, patients still
reported improved VAS6.
Burke et al. demonstrated the efficacy of IASTM in relieving CTS pain. As with
the Crothers study, while IASTM did answer the POEM, both modalities of IASTM as
well as manual muscle work were effective in decreasing pain. However, due to small
patient sample sizes, clinically meaningful differences between IASTM and manual soft
tissue manipulation interventions were small7. Accounting for patient drop off, a total of
22 patients completed the study, with 12 in the IASTM treatment arm7. Immediately
after as well as three months post treatment, improvements were still noted in both the
IASTM and manual muscle work groups, and while there was no statistically significant
difference in those improvements between modalities, it was encouraging again that the
treatment results lasted well after the treatment was applied.
Finally, Lee et al. demonstrated that IASTM was superior to an exercise program
of stretching and stationary bike riding for chronic low back pain sufferers. Statistically
significant decreases in pain levels were noted in the pre and post intervention group for
the IASTM treatment arm, while this was not the case for the exercise arm8. This study
was only conducted over one month of time. Another limitation to this study is that it
was never explicitly stated how frequently each intervention was applied over the
duration of the four weeks. This study also specifically observed the effects of IASTM
on patients with low back pain that was at least 90 days or more in duration, narrowing
the focus to chronic pain patients only8.
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IASTM is a relatively safe modality that involves a hand held rigid tool, typically
made of stainless steel that is applied over MSK tissue in a brushing or sweeping motion
after a frictionless emollient is applied to the skin. It is claimed that the instruments
resonate in the clinician’s hands, allowing the clinician to isolate MSK adhesions and
restrictions,

therefore

mobilizing

myofascial

restrictions

or

scar

tissue6.

Contraindications to this therapy are very limited, but include any open wound over the
area of treatment, uncontrolled hypertension, over a gravid uterus, over unhealed
fractures, and in patients taking anticoagulants9.

Access to this type of therapy is

relatively open; multiple professionals that utilize manual therapy become certified in one
form of IASTM. However, this type of therapy is typically considered either physical
therapy or massage therapy, and as such several insurances either do not cover it at all, or
a large portion of the cost of the therapy will come out of the patient’s pocket, which may
limit access to care. Regardless, it is relatively low in cost, especially when compared to
more invasive measures such as surgical intervention.
In general between the three RCTs, there were other limitations that may make it
more difficult to equally compare. Because the modality of this intervention is very
physical in nature, it makes it difficult to truly blind the patient subjects as far as what
form of therapy they are receiving. The Crothers study required an initial VAS score of
at least 2 out of 106 while the Burke study required an initial score of 33mm out of 1007,
and the Lee study had a minimum requirement of 17mm out of 100 on the VAS8. The
varying requirements across studies make the interpretation of each result all the more
subjective.

Additionally, the manner in which the patients developed their pain

symptoms was never disclosed. In other words, patients enrolling in these studies could
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be complaining of pain that originated from a wide range of injuries. The Lee study did
not exclude patients who were taking pain medications or undergoing other forms of
treatment for the area of pain being studied8 while the other two studies did. None of the
studies evaluated the efficacy of IASTM in regards to pediatric injuries.
CONCLUSION
The findings of all three studies have demonstrated that there is a
statistically significant decrease in pain when patients with MSK injuries are treated with
IASTM. While it may seem discouraging that two of the three studies proved it did not
matter the type of physical intervention that was applied to still get benefit, there is
something to be said about the perceived healing nature of manual therapies. To be more
certain of the outcomes of all three studies, additional research should be done with larger
study population numbers. Additionally, it would be beneficial to have individual studies
on the efficacy of IASTM on acute injury recovery as well as separate studies evaluating
the efficacy of IASTM on more chronic injuries. In this way it can be determined if there
is a more beneficial time to intervene with IASTM therapy.

REFERENCES
1. Cardenas CP, Burge SK, Kizerian G. Musculoskeletal Manifestations in Primary
Care . Musculoskeletal Manifestations in Primary Care.
https://iims.uthscsa.edu/sites/iims/files/RRNet/FINAL%20-%20Cardenas.pdf.
Accessed October 1, 2017.
2. Robert L. Musculoskeletal Hits Top 10 in Primary Care Visits. Musculoskeletal
Hits Top 10 in Primary Care Visits.
www.physicianspractice.com/printpdf/211949. Published June 23, 2015.
Accessed October 1, 2017.
3. Giannitrapani KF, Ahluwalia SC, Mccaa M, Pisciotta M, Dobscha S, Lorenz KA.
Barriers to Using Nonpharmacologic Approaches and Reducing Opioid Use in
Primary Care. Pain Medicine. 2017. doi:10.1093/pm/pnx220.
4. Kerr JI, Burri A. Genetic and epigenetic epidemiology of chronic widespread
pain. Journal of Pain Research. 2017;Volume 10:2021-2029.
doi:10.2147/jpr.s143869.
5. Babatunde OO, Jordan JL, Windt DAVD, Hill JC, Foster NE, Protheroe J.
Effective treatment options for musculoskeletal pain in primary care: A
systematic overview of current evidence. Plos One. 2017;12(6).
doi:10.1371/journal.pone.0178621.
6. Crothers AL, French SD, Hebert JJ, Walker BF. Spinal manipulative therapy,
graston technique(R) and placebo for non-specific thoracic spine pain: A
randomised controlled trial. Chiropr Man Therap. 2016;24:16-016-0096-9.
eCollection 2016. doi: 10.1186/s12998-016-0096-9.
7. Burke J, Buchberger DJ, Carey-Loghmani MT, Dougherty PE, Greco DS,
Dishman JD. A pilot study comparing two manual therapy interventions for carpal
tunnel syndrome. J Manipulative Physiol Ther. 2007;30(1):50-61. doi: S01614754(06)00313-7.
8. Lee JH, Lee DK, Oh JS. The effect of graston technique on the pain and range of
motion in patients with chronic low back pain. J Phys Ther Sci. 2016;28(6):18521855. doi: 10.1589/jpts.28.1852.
9. Hyde TE. Graston Technique Indications and Contraindications. Spine Health.
https://www.spine-health.com/treatment/chiropractic/graston-techniqueindications-and-contraindications. Published May 13, 2013. Accessed December
8, 2017.

